Overview

The Prolonging Effect of Dexmedetomidine on Spinal Anesthesia Through Different Routes if Administrations

Status:
NOT_YET_RECRUITING
Trial end date:
2025-09-01
Target enrollment:
Participant gender:
Summary
This prospective, double-blinded, randomized clinical trial aims to examine the effects of combining isobaric bupivacaine with dexmedetomidine administered intrathecally (IT), compared to the combination of isobaric bupivacaine administered intrathecally and dexmedetomidine administered intravenously (IV), on spinal anesthesia prolongation time in minutes, time of regression from Bromage score 3 to 0.
Phase:
PHASE4
Details
Lead Sponsor:
King Abdulaziz Medical City